CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3710
+0.0010 (0.27%)
At close: Jun 9, 2026, 4:00 PM EDT
0.3700
-0.0010 (-0.27%)
After-hours: Jun 9, 2026, 6:58 PM EDT

CollPlant Biotechnologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4.265.5911.9126.6729.6513.15
Short-Term Investments
-----30.15
Cash & Short-Term Investments
4.265.5911.9126.6729.6543.3
Cash Growth
-60.30%-53.05%-55.35%-10.05%-31.52%1199.10%
Accounts Receivable
0.0100.15-0.010.27
Inventory
0.680.570.440.711.431.08
Other Current Assets
0.590.580.680.630.570.44
Total Current Assets
5.546.7513.1828.0231.6645.09
Net Property, Plant & Equipment
3.513.895.285.865.685.68
Other Intangible Assets
0.060.070.130.190.250.24
Other Long-Term Assets
0.080.080.120.060.190.21
Total Assets
9.1810.7918.7134.1337.7751.22
Accounts Payable
0.640.610.870.981.131.03
Accrued Expenses
1.011.251.291.651.441.43
Current Portion of Leases
0.790.810.810.620.530.52
Unearned Revenue
-----0.03
Total Current Liabilities
2.442.672.973.253.113.01
Long-Term Leases
1.862.032.282.542.383.09
Total Long-Term Liabilities
1.862.032.282.542.383.09
Total Liabilities
4.34.75.255.795.496.1
Common Stock
6.275.494.984.984.874.66
Additional Paid-in Capital
127.53126.4122.8121.07118.1114.22
Accumulated Other Comprehensive Income
-0.97-0.97-0.97-0.97-0.97-0.97
Retained Earnings
-127.94-124.84-113.35-96.74-89.72-72.8
Shareholders' Equity
4.896.0813.4728.3432.2845.12
Total Liabilities & Equity
9.1810.7918.7134.1337.7751.22
Total Debt
2.652.853.083.162.913.61
Net Cash (Debt)
1.612.758.8323.5226.7439.69
Net Cash Growth
-41.24%-68.91%-62.46%-12.07%-32.63%-
Net Cash Per Share
0.130.230.772.062.423.32
Book Value
4.896.0813.4728.3432.2845.12
Book Value Per Share
0.380.501.182.492.933.77
Tangible Book Value
4.836.0113.3328.1532.0444.88
Tangible Book Value Per Share
0.380.491.162.472.903.75
SEC Filings: 10-K · 10-Q